Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001985496-25-000003
Filing Date
2025-11-13
Accepted
2025-11-13 20:32:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3467
  Complete submission text file 0001985496-25-000003.txt   5131
Mailing Address 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130 (858) 567-7770
GYRE THERAPEUTICS, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-51173 | Film No.: 251480614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GYRE THERAPEUTICS, INC. 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130
Business Address
Ye Weiguo (Reporting) CIK: 0001985496 (see all company filings)

Type: 144